For patients looking for long term results…

Gain control of your weight the right way with Semaglutide


Everyone’s talking about GLP1’s like

Semaglutide and Tirzepatide...

On average, people on Ozempic or Wegovy lose 15% of their weight in a year or less*.

But did you know that it does more than just help you lose weight?

GLP1’s like Semaglutide were a therapy for Alzheimer’s and Dementia patients to prevent further decline (link). In fact, GLP1’s are a neuroprotectant that increases stem cell proliferation, and increases neurons (dendritic growth)(link).

Weight loss was just a happy side effect.

The real reason you should be taking GLP1’s like Semaglutide isn’t just for weight loss, it should be for your anti-aging plan.

Every anti-aging plan needs to include brain protection. After all, Alzheimer’s Disease and Dementia is still the 6th leading cause of death in the US. We need to protect the brain, and we need to protect it early.

With this one peptide, you’re protecting your brain and your body from the effects of being overweight. Imagine your life without those extra 20-30 lbs. That you’re carrying 24/7. Multiply that by decades, and you will understand the wear and tear that excess weight causes to 
your health.


Additional benefits of GLP 1's include:


Good for Bone Health & Osteoarthritis (1)


Good for Muscle
Health (2)


Good for the
Microbiome (3)


Helps Infertility and
PCOS (4)


Improves Cardiovascular Health & Lipid Profiles (5)


Good for your Immune System Modulation (6)


Alleviates Depression (7)


Improves Sleep (8)

1. Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, Zhang Y, Ding S. The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment. Front Pharmacol. 2021 Jun 14;12:697442. doi: 10.3389/fphar.2021.697442. PMID: 34220521; PMCID: PMC8243369 (Link)

2. Chai W, Zhang X, Barrett EJ, Liu Z. Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin’s metabolic action in the presence of insulin resistance. Diabetes. 2014 Aug;63(8):2788-99. doi: 10.2337/db13-1597. Epub 2014 Mar 21. PMID: 24658303; PMCID: PMC4113068 (Link)

3. Abdalqadir, N.; Adeli, K. GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk. Microorganisms 2022, 10, 2061. (Link)

4. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695–709. doi: 10.1210/clinem/dgaa285. PMID: 32442310; PMCID: PMC7457958 (Link)

5. Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci. 2021 May 11;17(8):2050-2068. doi: 10.7150/ijbs.59965. PMID: 34131405; PMCID: PMC8193264 (Link)

6. Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X, Zhong J. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol. 2022 Dec 8;13:997578. doi: 10.3389/fimmu.2022.997578. PMID: 36569936; PMCID: PMC9772276 (Link)

7. Kim YK, Kim OY, Song J. Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function. Front Pharmacol. 2020 Aug 14;11:1270. doi: 10.3389/fphar.2020.01270. PMID: 32922295; PMCID: PMC7456867 (Link)

8. Sultana R, Sissoho F, Kaushik VP, Raji MA. The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome. Life (Basel). 2022 Aug 12;12(8):1222. doi: 10.3390/life12081222. PMID: 36013401; PMCID: PMC9410036 (Link)

However, there are sources that warn you NOT
to do GLP 1’s because of these false warnings...


side effects


Loss of


Other serious health


Myth #1

Semaglutide will give you terrible nausea, vomiting, and heartburn

Mythbuster: This is a common temporary side effect (and doesn’t happen in all patients, only small percentage) that can be mitigated with proper clinical guidance. For sensitive patients, these common temporary side effects can be managed, dampened, and even passed with the right prescription of GLP1, the right dose schedule, useful prebiotics, helpful supplements, and/or proper scheduling of your weekly injections.

Study of temporary gastrointestinal side effects of semaglutide (link).

Myth #2

Semaglutide will cause you to lose muscle mass

Mythbuster: Completely False. In fact, the opposite is true. GLP 1’s have helped muscle utilize glucose more efficiently, improving muscular structure and fibers (link).

It is however, important to note that any significant weight loss will cause loss of muscle mass. This is a natural effect of losing a lot of weight. This is why there is a right way to do GLP1’s. You must have a nutrition and exercise plan in place to support the upcoming weight loss to prevent the loss of muscle. This is key for the long term success and goal of weight management.


Myth #3

Semaglutide causes pancreatic cancer thyroid cancer, and other kinds of cancer

Mythbuster: False. There is ZERO evidence to support that Semaglutide (link) causes an increased risk of pancreatic cancer or other cancers. The thyroid cancer was in a rat model (link), and never evidenced in human trials. This Peptide simply doesn’t work on mechanism.

It’s not just about weight loss today… It’s about changing

the outlook of your health for your lifetime.

Start the journey now, the RIGHT way.

© 2023 Redox Medical Group. All Rights Reserved.

Scroll to Top